EP

Eversept Partners Portfolio holdings

AUM $992M
1-Year Est. Return 2.54%
This Quarter Est. Return
1 Year Est. Return
+2.54%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$884M
AUM Growth
-$85.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
75
New
Increased
Reduced
Closed

Top Buys

1 +$47.5M
2 +$18.5M
3 +$16.2M
4
GKOS icon
Glaukos
GKOS
+$15.6M
5
CYH icon
Community Health Systems
CYH
+$15.2M

Top Sells

1 +$40.2M
2 +$17.2M
3 +$15.8M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$12.8M
5
EW icon
Edwards Lifesciences
EW
+$12.6M

Sector Composition

1 Healthcare 98.66%
2 Financials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRA icon
1
Natera
NTRA
$26.4B
$126M 12.84%
893,721
+16,955
GSK icon
2
GSK
GSK
$86.9B
$102M 10.32%
2,623,246
-1,038,522
HCA icon
3
HCA Healthcare
HCA
$105B
$52.7M 5.35%
152,502
-23,306
SNDX icon
4
Syndax Pharmaceuticals
SNDX
$1.17B
$51.7M 5.26%
4,212,270
+3,868,870
VERA icon
5
Vera Therapeutics
VERA
$1.86B
$45.6M 4.63%
1,898,804
+298,789
RVTY icon
6
Revvity
RVTY
$11.5B
$31.6M 3.21%
299,087
-93,431
HQY icon
7
HealthEquity
HQY
$8.31B
$31.1M 3.16%
351,976
-34,721
INSP icon
8
Inspire Medical Systems
INSP
$2.29B
$29.7M 3.02%
186,425
-107,877
PTGX icon
9
Protagonist Therapeutics
PTGX
$4.66B
$26.5M 2.69%
547,116
-131,671
CYH icon
10
Community Health Systems
CYH
$574M
$22.8M 2.32%
8,458,020
+5,631,020
ZIMV
11
DELISTED
ZimVie
ZIMV
$22.5M 2.28%
2,079,380
+8,600
TEVA icon
12
Teva Pharmaceuticals
TEVA
$21.7B
$21.7M 2.2%
1,410,765
-831,360
PCVX icon
13
Vaxcyte
PCVX
$5.48B
$21M 2.14%
557,070
+429,482
BRKR icon
14
Bruker
BRKR
$5.92B
$20.8M 2.12%
499,207
+264,273
CNC icon
15
Centene
CNC
$16.7B
$20.7M 2.1%
340,339
+151,846
VRDN icon
16
Viridian Therapeutics
VRDN
$2.06B
$18.6M 1.89%
1,377,674
+597,676
NBIX icon
17
Neurocrine Biosciences
NBIX
$14.3B
$18.5M 1.88%
+167,243
UTHR icon
18
United Therapeutics
UTHR
$18.9B
$17.7M 1.8%
57,489
+13,786
TECH icon
19
Bio-Techne
TECH
$10.3B
$16.4M 1.67%
280,117
-19,193
BCRX icon
20
BioCryst Pharmaceuticals
BCRX
$1.52B
$16.3M 1.65%
2,172,436
+192,124
GKOS icon
21
Glaukos
GKOS
$4.28B
$15.6M 1.59%
+158,957
IONS icon
22
Ionis Pharmaceuticals
IONS
$11.3B
$15.6M 1.58%
517,021
+302,069
TVTX icon
23
Travere Therapeutics
TVTX
$2.5B
$14.6M 1.49%
816,254
+325,958
GMED icon
24
Globus Medical
GMED
$8.41B
$14.1M 1.43%
+192,893
CLDX icon
25
Celldex Therapeutics
CLDX
$1.77B
$12.6M 1.28%
696,499
-23,337